Impaired tissue barriers as potential therapeutic targets for Parkinson ’s disease and amyotrophic lateral sclerosis

AbstractThe blood-brain barrier and the intestinal barrier show signs of disruption in patients with idiopathic Parkinson ’s disease (PD) and animal models of nigrostriatal degeneration, and likewise in amyotrophic lateral sclerosis (ALS) models. A substantial body of evidence shows that defects in epithelial membrane barriers, both in the gut and within the cerebral vasculature, can result in increased vulnerability of tissues to external factors potentially participating in the pathogenesis of PD and ALS. As such, restoration of tissue barriers may prove to be a novel therapeutic target in neurodegenerative disease. In this review, we focus on the potential of new intervention strategies for rescuing and main taining barrier functions in PD and ALS.
Source: Metabolic Brain Disease - Category: Neurology Source Type: research